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Aim: The present study determined the extent to which individual differences in responses to the psychostimulating effect of nicotine during adolescence predict similar individual differences during adulthood in rats. We also
examined the possible long-term effects of adolescent nicotine exposure on adult prepulse inhibition (PPI) of the
acoustic startle response, a measure of sensorimotor gating ability.
Methods: During the adolescent phase, rats were administered saline, 0.10, 0.40, or 0.60 mg/kg nicotine via subcutaneous injections for 8 days, and motor activity was measured daily. During the adult phase, these rats were
treated with the same nicotine dose as in adolescence for 8 additional days. The adolescent saline rats (now adults)
were subdivided into four groups and administered saline, 0.10, 0.40, or 0.60 mg/kg nicotine, respectively. PPI was
assessed 12 days after the last nicotine treatment.
Results: During both phases, nicotine increased motor activity across test days in a dose-dependent manner. Motor
activity of rats treated with nicotine during adolescence was positively correlated with the activity recorded from
the same rats during adulthood. In both phases, there were profound individual differences in the responses to the
nicotine treatments. In addition, adolescent rats treated with nicotine did not show decreased motor response to
the initial exposure to nicotine. Finally, adolescent exposure to nicotine at 0.4 mg/kg, but not adulthood exposure
to the same dose of nicotine, produced a robust disruption of PPI, with individual rats showing different degrees
of PPI disruption.
Conclusion: These findings suggest that adolescent rats have increased sensitivity to the psychostimulating effect
and decreased sensitivity to the aversive effect of nicotine. Also, nicotine exposure during adolescence may have
long-term detrimental effects on sensorimotor gating ability.
Keywords: adolescent rat; nicotine; motor activity; prepulse inhibition of acoustic startle
Introduction
Several lines of evidence from epidemiological studies suggest that, compared with adults, adolescents
may have enhanced vulnerability to nicotine use[1].
After their initial experience with tobacco, adolescents report fewer aversive effects (eg, nausea, coughs,
and dizziness) and more positive effects (eg, euphoria, heightened arousal and attention, reduced stress
and anxiety) than adults[2]. Persons who start smoking as adolescents also experience more difficulty quitting than those who start as adults[3]. Finally, there is
also evidence suggesting that the earlier an individual
starts smoking, the more likely he/she will become a
lifelong smoker[4].
Research in animal models is in agreement with
these clinical observations. Adolescent rats are more
sensitive to the positive rewarding effects of nicotine

and less sensitive to its negative aversive effects than
adult rats. With regard to the positive effects of nicotine, adolescent female rats acquire intravenous nicotine self-administration more rapidly than adults[5].
They also show a higher self-administration rate during both adolescent and adult periods relative to rats
that initiate nicotine self-administration as adults[6, 7]. In
addition, administration of relatively low doses of nicotine results in place preference in adolescents but not
in adults[8-10]. With regard to the aversive effects of nicotine, O’Dell et al (2004) found that adolescent rats displayed fewer somatic signs of nicotine withdrawal (eg,
eye blinks, body and head shakes, ptosis, teeth chattering, and yawns) than adult rats, even when blood
levels of nicotine were equivalent in both groups[11].
Moreover, in an elevated plus maze test, Wilmouth
and Spear observed that adolescent rats displayed less
anxiety-like behaviors than adults following nicotine
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withdrawal[12].
Despite enhanced vulnerability, only a small percentage of the people who start smoking in adolescence become addicted to nicotine. In the US, more
than 60% of young people try smoking, but only about
one-third to one-half of them become daily smokers[13].
This clearly suggests that there are marked individual
differences in susceptibility to nicotine addiction. Clinical studies suggest that psychosocial factors, such as
peer and parental influences[14] and behavioral characteristics associated with adolescence, including risk
taking, novelty seeking, and impulsivity[15, 16], are likely
contributing factors to an individual’s vulnerability to
drug abuse. However, preclinical work aimed at elucidating the neurobiological and behavioral underpinnings of such individual vulnerability is still lacking.
In the present study, we examined to what extent
individual differences in the behavioral response to the
psycho-stimulating effect of nicotine during adolescence
predict the similar individual differences observed in
adulthood. Motor activity is a well-established measure of the psychostimulating effect of nicotine and
has been used in both adolescent and adult rats[17-19].
We recorded rat motor activity in response to nicotine
treatment at both the adolescent and adult phases. We
then examined the possible correlations between these
two sets of data. We also examined the individual vulnerability to the possible detrimental effects of adolescent nicotine exposure on adult cognitive functions. To
this end, we measured the prepulse inhibition (PPI) of
the acoustic startle response in adult rats that had been
exposed to different doses of nicotine treatment during
adolescence and/or during adulthood. PPI is a measure of the reduction in the startle response to a strong
acoustic stimulus when that stimulus is shortly preceded by a weaker prepulse stimulus. Specifically, PPI
assesses sensorimotor gating, the neural process controlling the integration and processing of sensory information, which is usually thought of as a pre-attentive
filtering mechanism. Nicotine-dependent adolescent
rats, but not adult rats, show impairment in PPI upon
nicotine withdrawal[12]. To date, no study has examined the long-term negative consequences of adolescent nicotine exposure on PPI in adult rats and the
variations in the sensitivity to this detrimental effect
across individuals.
Materials and methods
Animals The subjects were 79 Sprague-Dawley rats
(42 males and 37 females) from 10 litters (7-8 rats from
each litter). The dams were purchased from Charles
River Inc. (Portage, MI) on gestation days 13-15. After
arrival, the pregnant rats were housed individually, in
plastic tubs lined with aspen shavings in a colony on
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a 12-h light-dark cycle (lights on at 6:30 am). The temperature in the humidity-controlled colony was maintained at approximately 23°C. Starting one or two days
before the first possible expected parturition date (gestation days 22-23), the pregnant females were monitored every morning for signs of parturition. Once the
dams were found with pups in the morning (the day
designated postnatal day 1, PND 1), each litter was
culled to 8 pups (4 males and 4 females with the most
visible milk bands). The dams and their litters were
housed together for 22 days, after which the pups were
weaned from their mothers and housed 4 per cage
(same-sex littermates). At PND 45, the pups were separated and housed in same-sex pairs for the remainder of the experiment. All animal procedures were
conducted in accordance to the National Institutes
of Health Guide for the Care and Use of Laboratory
Animals and approved by the University of Nebraska
Institutional Animal Care and Use Committee.
Locomotor activity recording apparatus Five identical two-compartment chambers custom designed and
manufactured by Med Associates (St Albans, VT) were
used for the experiments. Each box was housed in a
ventilated, sound-insulated isolation cubicle (96.52 cm
wide × 35.56 cm deep × 63.5 cm high). Each box was 64
cm long, 30 cm high (from grid floor), and 24 cm wide
and was divided into two equal-sized compartments
by a partition with an arch style doorway (15 cm high
× 9 cm wide at base) and a 4 cm high barrier. The grid
floor consisted of 40 stainless-steel rods (0.48 cm diameter), spaced 1.6 cm apart center to center. Below the
floor was a stainless steel tray used to collect urine and
feces. Illumination was provided by two houselights
mounted at the top of each compartment. Activity was
recorded by a set of 16 photobeams (ENV-256-8P, 3.175
cm center-to-center) affixed at the bottom of the box
(3.5 cm above the grid floor) and controlled by Med
Associates computer programs. Background noise (74
dB) was provided by a ventilation fan affixed at the top
corner of each isolation cubicle.
Prepulse inhibition of acoustic startle reflex apparatus All prepulse inhibition testing was performed using
six Startle Monitor Systems (Kinder Scientific, Julian,
CA). Each system, controlled by a PC, was housed in
a compact sound attenuation cabinet (35.56 cm wide
× 27.62 cm deep × 49.53 cm high). A speaker (diameter: 11 cm) mounted on the cabinet’s ceiling was used
to generate acoustic stimuli (70 dB-120 dB). The startle
activity was measured by a piezoelectric sensing platform on the floor. During testing, rats were placed in a
rectangular box made of transparent Plexiglas (19 cm
wide × 9.8 cm deep × 14.6 cm high) with an adjustable
ceiling positioned atop the box, providing only limited
restraint while prohibiting ambulation.
Drugs Doses of nicotine hydrogen tartrate (Sigma,
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St Louis) are expressed as free base dissolved in 0.9%
saline. The nicotine solution was brought to a pH of
7.0±0.2 with NaOH. For adolescent rats (PND 28-42)
[15]
, 30-gauge needles were used to minimize animal
discomfort during injections; 26.5-gauge needles were
used for adults.
Experimental groups Seventy-nine Sprague-Dawley
rats (42 males and 37 female) were used in this experiment and were assigned to seven groups. Each group
consisted of 1 male and 1 female from different litters, with a total of 8-12 subjects (Table 1). Efforts were
made to assign an equal number of males and females
from each litter to each treatment group.
Experimental procedure After 2 days of habituation to the rectangular two-compartment boxes and
to the needle injections, all subjects (PNDs 28-35) were
injected with one of three doses of nicotine (0.1, 0.4,
0.6 mg/kg, sc) or saline, and they were immediately
placed in the testing boxes where motor activity was
measured for 30 min. Once the subjects became adults
(PND 70-71), handling was resumed (1 min/d). From
PND 72 to 79, rats were injected with their corresponding solution (saline, 0.1, 0.4, or 0.6 mg/kg nicotine, sc),
and their motor activity was tested (once daily).
Rats exposed to nicotine as adolescents received the
same dose of nicotine as adults. A subset of the rats that
had been exposed to saline as adolescents received nicotine for the first time as adults. As denoted in Table 1,
this protocol resulted in 7 experimental groups (Table
1). Lastly, on PND 80, all rats were injected with the
same dose of nicotine (0.4 mg/ kg, sc), and motor activity was recorded for 30 min. This test examined the
long-term behavioral sensitization effect of repeated
nicotine exposure during the adolescent and adult
phases using a common nicotine dose.
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On PND 92 to 96 (12 days after the last adult nicotine treatment), rats were tested daily for PPI across
five consecutive days[20]. In the first two test days (PND
92-93, Baseline tests), rats were placed individually
into the PPI boxes and exposed to 5 min of 70-dB white
background noise, which continued throughout the
entire testing session. The initial 5 min was followed
by 32 trials consisting of two different protocols presented in pseudorandom order: 17 “PULSE ALONE”
trials, each consisting of a 40 ms 120-dB noise burst
(the ‘pulse’), and 15 “PREPULSE+PULSE” trials consisting of a 20 ms noise burst of 73, 76, or 82 dB followed 100 ms later by the 120-dB pulse (5 trials at each
dB level). Startle magnitude was defined as the maximum force (measured in Newtons) applied by the rat
to the startle apparatus during a period of 100 ms after
the onset of the pulse stimulus. During the following
three days (PND 94-96), a slightly different PPI testing
procedure was used based on a previously reported
protocol[20]. Each test session consisted of five different
trial types: PULSE ALONE trials (n = 18), three types
of PREPULSE+PULSE trials (n = 30, 10 trials/ type)
identical to the ones run during baseline, and new split
76 dB trials, which consisted of two 20 ms 76 dB prepulses separated by 10 ms, followed 10 ms later by the
120 dB pulse (n = 10). The first and last four trials in
each PPI testing session were of the PULSE ALONE
type. All remaining trials were presented in pseudorandom order and were separated by a variable intertrial interval (mean 15 s, ranging from 9-21 s).
Data analysis Data from the adolescent and adult
phases were first analyzed separately using repeatedmeasures analyses of variance (ANOVAs) with a
within-subjects factor of test days and between-subjects factors of nicotine treatment and sex. Post hoc
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Tukey’s HSD tests were used to determine group differences. To examine how early adolescent nicotine
treatment impacts the effects of nicotine in adult rats,
data from the groups exposed to nicotine at both the
adolescent and adult phases were compared with data
of the groups exposed to the same treatment only at
the adult phase. In addition, linear regression tests
were employed to estimate the correlation between the
motor measurements obtained at the adolescent and
adult phases.
For the PPI data, startle responses in the PULSE and
PREPULSE+PULSE trials were used to calculate percent prepulse inhibition (%PPI) using the following
equation: %PPI=100-[(mean startle response to PREPULSE+ PULSE trials/mean startle response to PULSE
ALONE trials)*100]
We compared each pair of nicotine groups (eg, NicNic0.1 mg/kg and Sal-Nic-0.1 mg/kg) with the saline
group using repeated measures ANOVA with the nicotine treatment as a between-subjects factor, and test
days and levels of PPI as within-subject factors. If a
significant nicotine treatment effect was detected, oneway ANOVA was used to examine the exact differences at the specific PPI level and test days.
Results
Effect of nicotine treatment on motor activity during adolescence Overall, there was a significant effect
of “Sex” during adolescence (F(1, 65) = 9.57, P = 0.003)
and adulthood (F(1, 65) = 28.07, P < 0.001). The females
were generally more active than the males, which was
consistent with previous reports[9, 17]. There were no
significant interactions between “Sex” and other factors (eg, days and treatment) (Ps > 0.40); therefore, data
were combined for male and female subjects for the
rest of the analysis.
As shown in Figure 1A, during the adolescent phase,
nicotine increased motor activity progressively and in a
dose-dependent manner. This effect tapered off toward
the last two test days. Repeated measures ANOVA
indicated that there was a significant effect of nicotine
treatment (F(6,72) = 29.75, P < 0.001), test days (F(7,504) =
9.409, P < 0.001) and a significant interaction between
nicotine and test days (F(42, 504) = 11.741, P < 0.001). Post
hoc Tukey tests indicated that the nicotine 0.4 and 0.6
mg/kg groups were significantly different from the
nicotine 0.1 mg/kg group and the four saline groups
(Ps = 0.005) but did not differ from each other. The nicotine 0.1 mg/kg group was also significantly different from the four saline groups (Ps ≤= 0.010), which
were not significantly different from each other (all Ps
> 0.97). One-way ANOVAs on each of the 8 test days
showed that there were no group differences on the
first day of testing (F < 1), but differences did appear

by the second day of testing (P < 0.001). More importantly, there were substantial individual differences in
motor activity among the nicotine-treated adolescents
(= 2-fold), even among rats treated with the same dose
of nicotine. Figure 1B shows an example of such data
from the nicotine 0.4 mg/kg group.
Effect of nicotine treatment on motor activity during adulthood During the adult phase, nicotine also
increased motor activity progressively over successive test days (Figures 2A and 2B). Repeated measures ANOVA revealed a significant effect of nicotine
treatment (F(6,72) = 3.393, P = 0.005), test days (F(7,504)
= 97.227, P < 0.001) and an interaction between nicotine and test days (F(42, 504) = 6.632, P < 0.001). Prior adolescent nicotine exposure also affected adult responses
to nicotine, as there were differences between the rats
that had been exposed to nicotine during adolescence
versus those that only received nicotine during adulthood (see the circled data points in Figures 2A and 2B).
Among rats that had been exposed to nicotine during
adolescence, activity levels increased progressively
with time (Day: F(7, 280) = 34.88, P < 0.001; Treatment: F(3,
= 3.422, P = 0.026; Day × Treatment interaction: F(21, 280)
40)
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= 8.433, P < 0.001). The differences between one of the
nicotine treatment groups and the saline group started
to appear after four days of treatment and persisted
throughout the remaining test days (all Ps < 0.026).
Among rats first exposed to nicotine as adults, motor
activity was initially suppressed in a dose-dependent
manner (F(3, 42) = 12.06, P < 0.001). With repeated treatment, activity in the nicotine groups increased in a
dose-dependent fashion and eventually became higher
than that of the saline controls. The 0.4 mg/kg (but not
0.1 or 0.6 mg/kg) group was significantly different
from the saline group (Day 5-8: Ps < 0.003). The finding
that the nicotine’s initial suppressive effect was absent
in the adolescent nicotine rats suggests that adolescent
rats are less sensitive to the aversive and unpleasant
effects of nicotine.
Comparison of rats that had been exposed to nico-
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tine during adolescence to those that only received nicotine during adulthood further indicated that adolescent nicotine exposure altered adult motor responses
to nicotine in a dose-dependent manner. For the 0.1
mg/kg groups (Figures 3A), there was a significant
effect of Test (F(1, 154) = 11.25, P < 0.001), but no significant effect of Group or Group × Test interaction (Fs
= 1.215, Ps = 0.298). For the 0.4 mg/ kg groups (Figure 3B), there was a significant effect of Test (F(1, 154) =
89.179, P < 0.001) and a significant Group × Test interaction (F(7,154) = 2.170, P = 0.040); the main effect of
Group was not significant (F < 1). The adolescent nicotine (0.4 mg/kg) group had higher motor activities
at the early (day 1-3) and late (day 5-8) test days than
the adult nicotine (0.4 mg/kg) group. For the 0.6 mg/
kg groups (Figure 3C), however, there was a significant effect of Test (F(1, 147) = 44.99, P < 0.001), a significant effect of Group (F(1,21) = 8.719, P = 0.008), but no
significant interaction (F < 1). The rats exposed to 0.6
mg/kg nicotine as adolescents displayed consistently
higher motor activities than the adult nicotine group
throughout the entire test period. Similar to what was
observed in adolescent rats (Figure 1B), there were also
large individual differences in the motor response to
nicotine treatment in adult rats. Figure 3D depicts the
motor activity of individual rats in the nicotine-nicotine (0.4 mg/kg) group during adulthood.
The last nicotine injection was tested for behavioral
sensitization to nicotine. To this end, all rats were
injected with the same dose of nicotine (0.4 mg/kg, sc)
and tested for 30 min. We found that rats that had been
previously treated with nicotine (either during adolescence or adulthood) showed significantly higher motor
activities than the saline group rats, indicating a robust
sensitization effect (F(6, 78) = 29.106, P < 0.001) (Figure
3E). Prior adolescent nicotine treatment did not significantly potentiate the nicotine-induced sensitization
effect, as there were no significant differences between
the groups that received nicotine during both adolescence and adulthood and the groups that received nicotine only during adulthood (all P > 0.05).
Effect of early adolescence nicotine treatment on
PPI during adulthood To examine the long-term effect
of adolescent nicotine exposure on the rats’ cognitive
functions, we assessed the PPI from PND 92 to 96 (12
days after the last adult nicotine treatment) daily for
5 consecutive days. One rat from the nicotine-nicotine 0.6 mg/kg group died unexpectedly, leaving only
10 rats from that group to be tested for PPI. Figure 4
shows the mean percentage PPIs (prepulses: 3, 6, and
12 dB above background) for the 6 nicotine groups,
each plotted together with the saline control group.
For the two 0.1 mg/kg groups (Figure 4A), repeated
measures ANOVA with the nicotine treatment as a
between- subject factor and test days and levels of PPI
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as within-subject factors, showed that there was a significant effect of test days (F(4, 116) = 32.180, P < 0.001)
and a significant effect of levels (F(2,58) = 145.444, P <
0.001), but no significant effect of nicotine treatment or
any interaction involving nicotine treatment and other
factors (all Ps > 0.05). This suggests that this concentra-
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tion of nicotine (0.1 mg/kg) given during adolescence
and adulthood did not alter PPI significantly.
For the two 0.4 mg/kg groups (Figure 4B), repeated
measures ANOVA showed that there were significant
effects of test days (F(4, 116) = 33.913, P < 0.001), PPI levels (F(2,58) = 178.968, P < 0.001), and nicotine treatment
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(F(2,29) = 4.094, P = 0.027), as well as a significant threeway interaction among these factors (F(16,232) = 1.901,
P = 0.021). One-way ANOVA followed by post hoc
Tukey’s test indicated that rats that treated with 0.4
mg/kg nicotine at both adolescent and adult phases
exhibited significantly lower PPIs than the rats that
were only treated with nicotine during the adult phase
and the saline control rats. This disruptive effect of
adolescent nicotine treatment was more conspicuous
on days 4 and 5.
For the two 0.6 mg/kg groups (Figure 4C), repeated
measures ANOVA found a significant effect of test
days (F(4, 108) = 27.893, P < 0.001) and a significant effect
of levels (F(2,54) = 213.192, P < 0.001). There was no effect
of nicotine treatment or any interaction involving nicotine treatment and other factors (all Ps > 0.05), suggesting that nicotine 0.6 mg/kg, like nicotine 0.1 mg/kg,
also did not significantly disrupt PPI when the drug
was given during adolescence.
To illustrate the individual vulnerability to this disruptive effect, we plotted the 76 dB PPI data from all
rats in the Nic-Nic 0.4 mg/kg group. As can be seen in
Figure 4D, there were substantial differences in the PPI
performance across individuals.
Correlation analysis of motor activity measured
at both phases We used linear regression to examine
the correlation between motor activity in the adolescent and adult phase. Figure 5 shows motor activity
averaged over the 8 drug days (group means±SEM) for
individual adolescent and adult nicotine-treated rats.
These two sets of data were highly correlated (Pearson correlation r = 0.548, P = 0.001). The linear regression equation was the following: Y (adult) = 1347.91 +
0.94* x (adolescent). r2 = 0.301. The coefficient was also
significant (F(1, 34) = 14.61, P = 0.001), suggesting that the
individual differences in the responses to nicotine that
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were present during adolescence persisted through to
adulthood.
Thus, it may be possible to predict adult motor activity based on motor activity recorded during adolescence.
We next examined whether there was any relationship between an individual rat’s motor response to
nicotine during adolescence and its PPI performance
during adulthood. To this end, we used the Bivariate Correlations procedure and computed the Pearson’s correlation coefficient between the motor activity
data obtained during adolescence in adolescent nicotine-treated rats and their PPI data recorded during
the adult phase. There were no significant correlations
between these two sets of data (all Ps > 0.05), suggesting that the individual differences in motor response
to nicotine during adolescence do not directly predict
sensorimotor gating in adulthood.
Discussion
The present study demonstrates that individual differences in the motor responses to the psychostimulating effect of nicotine during adolescence are positively
correlated with the differences seen during adulthood.
This suggests that individual sensitivity to the effects of
nicotine, or even susceptibility to nicotine abuse, may
be detected during the early adolescent period. We
also found different patterns of motor responses to nicotine between adolescent and adult rats. Both adolescent and adult rats showed a dose-dependent increase
in motor responses to the repeated nicotine treatment.
However, the adolescent nicotine-treated rats were less
sensitive to the initial motor suppressive effect or aversive effect of nicotine exposure than adult rats. Specifically, the adolescent nicotine-treated rats did not show
decreased motor activity on the first 2 days of nicotine
treatment, whereas adult rats did. Early adolescent
nicotine exposure also abolished the motor-depressing effect in adult rats that had been treated with nicotine during adolescence. Adolescent nicotine exposure
significantly potentiated later adult motor response to
nicotine, such that adolescent nicotine exposure rats
showed significantly higher motor activity than those
that only received nicotine during adulthood. Finally,
we found that adolescent exposure to nicotine 0.4 mg/
kg, but not to 0.1 and 0.6 mg/kg, caused a disruption
in the PPI, and that there were large individual differences in PPI performance.
Adolescents as well as adults exhibited a progressively enhanced motor response (eg, sensitization) to
nicotine’s activity-increasing action over the 8 days of
drug treatment (see Figures 1A and 2A and 2B). This
sensitization effect was further confirmed in the final
nicotine test, which showed that rats that had been pre-
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viously treated with nicotine had significantly higher
motor activity levels than the saline control rats (Figure
3E). Of interest is the finding that there were no significant differences in sensitization between the groups
that were exposed to nicotine only during adulthood
and those that were exposed to nicotine during both
developmental phases. This lack of long-term behavioral sensitization of adolescent nicotine exposure may
be due to a ceiling effect. The challenge test was conducted after 8 consecutive days of nicotine treatment
during adulthood, and any possible adolescent nicotine sensitization effect might have been masked by
the adult nicotine treatment. These activity patterns
are consistent with data reported in the literature[17,
21-23]
. We also found that adolescent rats might be less
sensitive to the initial aversive effect of nicotine than
adult rats, as adolescent rats did not show decreased
motor activity on the first 2 days of nicotine treatment,
whereas adult rats did. This initial motor suppressing
effect has been linked to the aversive effect of nicotine
that tolerates out rather rapidly across-species[23]. This
finding is consistent with the results from Vastola et
al[9], who showed that, relative to adults, adolescent
rats were less sensitive to the nicotine’s motor-suppressing effect and more sensitive to the psychomotor effect of nicotine. More interestingly, early adolescent nicotine exposure completely blocked this acute
motor-suppressing effect of nicotine in adult rats (Figure 2A).
As mentioned in the Introduction, previous work
has shown that adolescent rats are less sensitive to
nicotine withdrawal. Specifically, they often display
fewer somatic signs of nicotine withdrawal than adult
rats[11], they fail to develop a conditioned place aversion induced by mecamylamine-precipitated nicotine withdrawal[24], and they display less anxiety-like
behaviors following nicotine withdrawal[12]. Our finding that adult rats that had been exposed to nicotine
during adolescence also showed less sensitivity to
the nicotine’s motor suppressive effect during adulthood adds to this literature. To the extent that the negative effects of nicotine and nicotine withdrawal play
a crucial role in the maintenance of long-term nicotine
use[25], our finding suggests that adolescent nicotine
exposure may have persistent effects leading to more
tenacious nicotine addiction in adults.
The finding that early adolescent nicotine exposure
enhanced motor responses to adult nicotine treatment is also consistent with what has been reported
in the literature. For example, Faraday et al reported
that male rats first exposed to nicotine as adolescents
exhibit greater sensitivity to the motor stimulating
effect of nicotine when they are retested during adulthood compared with rats that are exposed to nicotine
for the first time during adulthood[18]. Elliot et al found
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a similar effect in female rats[17].
In this study, we also found that rats that were treated
with nicotine 0.4 mg/kg during adolescence and adulthood, but not rats that were treated with the same dose
of nicotine only during adulthood, showed impaired
PPI when they were assessed during the abstinence
period (12 days after the last nicotine treatment) relative to the saline rats (Figure 4B). We also observed
large individual differences in PPI performance over
the 5 test days (Figure 4D). Previous studies have
found that nicotine increases PPI in Sprague-Dawley adult rats, but not in adolescent rats[26-28], whereas
nicotine withdrawal generally has no apparent effect
on PPI in adult rats[27, 28] but causes an acute disruption of PPI in adolescent rats[12]. We are not aware of
any study that has examined the long-term effects of
adolescent nicotine exposure on PPI in adult rats and
the individual sensitivity to this detrimental effect.
The PPI deficit observed in rats that were exposed to
nicotine 0.4 mg/kg at both adolescent and adulthood
phases could be attributed to two possible sources. The
first source would be the exposure to nicotine during
adolescence, while the second one would be the two
prior exposures to nicotine. Because we did not have
a group that was treated with 0.4 mg/kg nicotine only
during adolescence, it is impossible to identify which
of these two sources was responsible for the PPI deficit. However, the finding that rats exposed to nicotine
only during the adulthood phase did not show a PPI
deficit strongly suggests that adolescent nicotine exposure is critical in causing the PPI deficit. This point is
also supported by a study by Wilmouth and Spear,
which reports that PPI was significantly disrupted in
adolescent rats previously exposed to nicotine, but not
in adult rats[12].
The underlying mechanisms that support such a
long-term effect of adolescent nicotine exposure on
adult PPI remain unclear. The mesolimbic dopamine
system is thought to be critically involved in PPI[29],
and this system undergoes developmental changes
during adolescence and overlaps with the neural circuitry regulating the positive and psycho-stimulating
effects of nicotine and nicotine withdrawal[15].
Therefore, we speculate that adolescent nicotine
exposure may permanently derail the developmental
trajectory of the mesolimbic dopamine system in a way
that leads to impaired cognitive functioning. Indeed,
previous work has shown that rats exposed to nicotine
during adolescence show increased catecholamine (eg,
norepinephrine and dopamine) turnover during the
treatment period, a drop in midbrain catecholamine
turnover upon immediate nicotine withdrawal, and
a later-emerging activation of these pathways during adulthood[30]. Adolescent rats exposed to nicotine also show an upregulation of nicotinic receptors[31]
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and an increase in nicotinic acetylcholine receptor
gene expression[32]. It should be noted that other neurochemical systems that are not directly involved in
the regulation of PPI and nicotine effects could also be
negatively affected by adolescent nicotine exposure.
This point is supported by the lack of significant correlation between an individual rat’s motor response to
nicotine during adolescence and its PPI performance
during adulthood. This suggests that neural systems
other than those involved in regulating the positive
and psychostimulating effects of nicotine and nicotine
withdrawal may contribute to the adolescent nicotineinduced PPI disruption. It would be valuable for future
research to comprehensively evaluate the cognitive
functions and emotional regulation of rats that were
exposed to nicotine during adolescence and to determine the possible neural and neurochemical mechanisms of the effects of nicotine on adolescents.
In summary, the present study shows that individual
adolescent rats show different sensitivity to the psycho-stimulating effect of nicotine, and these differences
observed during adolescence correlate positively with
the differences seen during adulthood. Early adolescent nicotine exposure enhances the motor responses
to nicotine and blocks the motor-depressing effect in
adult rats. Adolescent nicotine exposure also causes
PPI disruption in adult rats, and individual rats show
different degrees of vulnerability to this adverse effect
of nicotine. We conclude that individual differences
in sensitivity to the rewarding and aversive effects of
nicotine during adolescence may play a critical role in
determining nicotine addiction during adulthood.
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